---
title: "Progyny (PGNY) Receives a Hold from Canaccord Genuity"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/278706672.md"
description: "Canaccord Genuity analyst Richard Close has maintained a Hold rating on Progyny (PGNY) with a price target of $19.00. Close, a 4-star analyst with an 8.4% average return, also covers other healthcare stocks. Previously, Progyny received a Hold rating from TipRanks and a Buy rating from BTIG on March 6."
datetime: "2026-03-11T10:58:21.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/278706672.md)
  - [en](https://longbridge.com/en/news/278706672.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/278706672.md)
---

# Progyny (PGNY) Receives a Hold from Canaccord Genuity

Canaccord Genuity analyst Richard Close maintained a Hold rating on Progyny today and set a price target of $19.00.

### Claim 70% Off TipRanks Premium

-   Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
-   Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential

According to TipRanks, Close is a 4-star analyst with an average return of 8.4% and a 47.93% success rate. Close covers the Healthcare sector, focusing on stocks such as Talkspace, HealthStream, and Progyny.

In addition to Canaccord Genuity, Progyny also received a Hold from TipRanks – xAI’s xAi Medical – Healthcare Information Services in a report issued on February 28. However, on March 6, BTIG assigned a Buy rating to Progyny (NASDAQ: PGNY).

### Related Stocks

- [PGNY.US](https://longbridge.com/en/quote/PGNY.US.md)

## Related News & Research

- [Progyny Commemorates 10 Years of Redefining Women’s Health and Family Building Care | PGNY Stock News](https://longbridge.com/en/news/281377491.md)
- [Is Progyny (PGNY) Pricing Make Sense After Prolonged Share Price Slump?](https://longbridge.com/en/news/281607580.md)
- [XAI reorganizes its engineering team ahead of SpaceX IPO](https://longbridge.com/en/news/282105851.md)
- [TD Cowen Sticks to Its Buy Rating for Ceribell, Inc. (CBLL)](https://longbridge.com/en/news/282751759.md)
- [Progyny Announces Settlement, Governance Reforms on Director Pay](https://longbridge.com/en/news/279092430.md)